CAP Member Quoted on New Prostate Cancer Study

Dr. Jeffry Simko Says New Study Can Help to Better Classify Patient RiskProstate Needle Biopsy Biomarker Predicts Tumor Aggressiveness By Labmedica International staff writers  A new study demonstrates the ability to measure and evaluate biomarkers from ribonucleic acid (RNA) expression data obtained from prostate needle biopsies. The data demonstrate a high concordance in the genomic signatures between needle biopsy samples and post-prostatectomy tissue samples.  The study showed that genetic information from prostate needle biopsy may be used to predict tumor aggressiveness and